RIXIT – O DRY (WFI)
Dual Antibiotic. Faster Recovery. Trusted Care.
Citric Labs presents RIXIT-O Dry WFI, a premium-quality dry syrup formulated with Cefixime 50 mg and Ofloxacin 50 mg per 5 ml. This dual-antibiotic combination offers broad-spectrum antibacterial action against susceptible bacterial infections in children. The product is manufactured under stringent quality standards, making it an excellent choice for PCD Pharma Franchise, pharma distributors, and healthcare professionals across India.
Composition
- Cefixime 50 mg
- Ofloxacin 50 mg/5 ml Dry Syrup with WFI
Key Benefits
- Broad-spectrum antibacterial activity
- Effective against various susceptible bacterial infections
- Helps control bacterial growth and infection
- Pediatric-friendly dry syrup formulation
- Easy reconstitution with WFI
- Pleasant taste for improved compliance
Product Description
RIXIT-O Dry WFI is a pediatric dry syrup containing Cefixime 50 mg + Ofloxacin 50 mg/5 ml, formulated to provide broad-spectrum antibacterial coverage against a wide range of bacterial infections. Manufactured by Citric Labs, it is an ideal choice for healthcare professionals and PCD pharma partners seeking high-quality pediatric antibiotic formulations. Use only under the supervision of a registered medical practitioner.
Related products
Why Choose Citric Labs for PCD Pharma Franchise?
- High-quality WHO-GMP certified products
- Monopoly-based PCD Pharma Franchise opportunities
- Strong product portfolio including pain management range
- Competitive pricing & high margins
- Reliable supply chain across India
